Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 233-238-0 | CAS number: 10099-59-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Study period:
- From 30 August 2012 to 14 March 2013
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: see 'Remark'
- Remarks:
- Well documented GLP study performed with lanthanum acetate according to OECD Guideline 473. We refer to the read across justification added in section 13 to the IUCLID file for extrapolation to lanthanum trinitrate. A maximal reliability score of 2 (reliable with restrictions) is assigned because the study has been used for read-across purposes in this dossier.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 013
- Report date:
- 2013
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.10 (Mutagenicity - In Vitro Mammalian Chromosome Aberration Test)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- in vitro mammalian chromosome aberration test
Test material
- Reference substance name:
- 100587-90-4
- Cas Number:
- 100587-90-4
- IUPAC Name:
- 100587-90-4
- Reference substance name:
- Lanthanum (3+) acetate
- IUPAC Name:
- Lanthanum (3+) acetate
- Details on test material:
- - Name of test material (as cited in study report): Lanthanum Acetate
- Physical state: Solid white powder
- Storage condition of test material: Room temperature in the dark under nitrogen
Constituent 1
Constituent 2
Method
Species / strain
- Species / strain / cell type:
- lymphocytes:
- Details on mammalian cell type (if applicable):
- Used whole blood was drawn from the peripheral circulation of a volunteer who had been previously screened for suitability.
- Metabolic activation:
- with and without
- Metabolic activation system:
- male rat liver S9 mix
- Test concentrations with justification for top dose:
- EXPERIMENT 1
- 4-hour exposure without S9 followed by 20-hour culture in treatment-free media: 25, 50, 100, 200, 400 and 800 μg/mL.
- 4-hour exposure with S9 followed by 20-hour culture in treatment-free media: 25,50, 100, 200, 400 and 800 μg/mL.
EXPERIMENT II
- 24-hour without S9:25, 50, 100, 200, 400 and 800 μg/mL.
- 4-hour with S9 and followed by 20-hour culture in treatment-free media: 25, 50, 100, 200, 400 and 800 μg/mL.
The purity of the test item was 95.59% and was accounted for in the formulations.
Test concentrations were selected based on the results of a preliminary study. The selection of the maximum dose level was primarily based on precipitate rather than the onset of toxicity in all exposure groups tested because it had persisted on to the slides at the end of exposure and the toxicity could have been caused by the small decrease in pH. - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: Minimal Essential Medium.
Controlsopen allclose all
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- mitomycin C
- Remarks:
- without S9
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- Remarks:
- with S9
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in medium
DURATION
- Exposure duration: 4 hours for experiment 1, 24 hours and 4 hours for experiment 2
NUMBER OF CELLS EVALUATED: The first 100 consecutive well-spread metaphases from each culture were counted; where there were approximately 30 to 50% of cells with aberrations. Slide evaluation was terminated at 50 cells. - Evaluation criteria:
- A positive response was recorded for a particular treatment if the % cells with aberrations, excluding gaps, markedly exceeded that seen in the concurrent control, either with or without a clear dose-relationship. For modest increases in aberration frequency a dose response relationship is generally required and appropriate statistical tests may be applied in order to record a positive response.
- Statistics:
- The frequency of cells with aberrations excluding gaps and the frequency of polyploid cells was compared, where necessary, with the concurrent vehicle control value using Fisher's Exact test.
Results and discussion
Test results
- Species / strain:
- lymphocytes: human
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Effects of pH: There was small significant change in pH when the test item was dosed into aqueous media, decreasing by more than 1 pH unit. Therefore, HEPES buffer was added (2% v/v) to buffer the pH change. The pH a was tested again in MEM during the Preliminary Toxicity test. Consequently, the change was small enough not to preclude testing the test item to the maximum dose level of 3160 μl/ml.
- Effects of osmolality: The osmolality did not increase by more than 50 mOsm.
- Precipitation: In Experiment I the maximum dose level selected for metaphase analysis was 200 μg/ml (with and without S9) due to the presence of precipitate on the slides. In Experiment II, the maximum dose level selected for metaphase analysis was therefore, 100 μg/ml in the absence and presence of S9, respectively.
- Other confounding effects: The test item was insoluble in dimethyl sulphoxide at 158 and 316 mg/ml and acetone at 316 mg/ml. However, the test item produced a doseable suspension at 31.60 mg/ml in an aqueous vehicle in solubility checks performed in-house. MEM at 31.60 mg/ml was, therefore, selected as the vehicle.
RANGE-FINDING/SCREENING STUDIES:
The dose range for the Preliminary Toxicity Test was 12.34 to 3160 μg/ml. The maximum dose was based on the maximum recommended dose level, 10 mM concentration. Precipitate observations were made from the blood-free cultures. In the exposure groups in the absence of S9, precipitate was noted at the end of exposure at and above 24.69 μg/ml. However, in the 4(20)-hour exposure group in the presence of S9, precipitate was observed at all dose levels tested. In addition, precipitate persisted after exposure on the slides at and above 197.5 μg/ml in the absence of S9 and at and above 49.38 μg/ml in the presence of S9. Haemolysis was also observed in the blood cultures at and above 790 μg/ml in the 4(20)-hour exposure groups and at and above 395 μg/ml in the continuous exposure group. Haemolysis in this instance is thought to be the result of disruption of the membranes of erythrocytes and is not an indicator of toxicity to lymphocytes.
Microscopic assessment of the slides prepared from the exposed cultures showed that metaphase cells were present up to 3160 μg/ml in both of the 4(20)-hour exposure groups. However, they were considered to be not suitable for scoring in the case of the exposure group dosed without S9. In the continuous exposure group, metaphase cells were present up to 1580 μg/ml. There were no scorable metaphases present at the dose level above. Clear dose-related reductions in mitotic index were observed in the 24-hour continuous exposure group, whilst toxicity was observed in the 4(20)-hour exposure groups the dose-relationship was less clear.
The selection of the maximum dose level was primarily based on precipitate rather than the onset of toxicity in all exposure groups tested because it had persisted on to the slides at the end of exposure and the toxicity could have been caused by the small decrease in pH.
COMPARISON WITH HISTORICAL CONTROL DATA:
- Vehicle: all vehicle (MEM) controls had frequencies of cells with aberrations within the range expected for normal human lymphocytes as determined by the in-house historical range of the laboratory.
- Positive controls: All the positive control items induced statistically significant increases in the frequency of cells with aberrations within the range determined by the in-house historical range of the laboratory, indicating that the sensitivity of the assay and the efficacy of the S9-mix were validated.
ADDITIONAL INFORMATION ON CYTOTOXICITY: In Experiments 1 and 2, the test item exhibited no dose-related inhibition of mitotic index
in the dose levels tested and, therefore was considered to be non-cytotoxic at the tested concentrations and under these experimental conditions. - Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Migrated from field 'Test system'.
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information):
negative
The test item was considered not to induce any significant increases in the frequency of cells with aberrations, which included at least one precipitating dose level, either in the absence or presence of metabolic activation. Therefore, lanthanum acetate was considered to be non-clastogenic.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.